FARICIMAB (Vabysmo®)

Clinical Indication

Wet age-related macular degeneration


In line with NICE TA800

Date of classification

July 2022


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.